SUMMARY We report two families selected from 124 genotyped Caucasian insulin-dependent diabetes mellitus (IDDM) families because of unusual features. In both families, all offspring are affected and four out of six bear the allele HLA-DR2 which is an uncommon phenotype among diabetic patients. Onset before the age of 1 year in all the patients of one family, association with optic atrophy in the other, and the existence of pairs of affected sibs of different HLA types in both, are infrequent findings and support the evidence of heterogeneity in IDDM.
The HLA-DR2 allele is found at a significantly lower frequency in patients with insulin-dependent diabetes mellitus than in the random population.12 This has led to the suggestion that a protective factor might be associated with this marker.3-5 We have genotyped 124 Caucasian IDDM patients, 53 of whom were included in a previous publication. 6 HLA typing for A, B, C, DR, and properdin factor B (Bf) alleles and haplotype assignment have been described elsewhere.6 DR2 was found in 12 index cases (gene frequency 0- In the case of family 1, a hypothesis can be put forward for unusual immunological mechanisms which could explain the extremely early onset of the disease in all three sibs: the mother developed autoanti-islet cell antibodies which were still present 34 years after onset of the disease. Although relatively frequent at the time of diagnosis, these antibodies decline in frequency in time. They belong mostly to the IgG class. In this case, it can be postulated that in passing through the placental barrier during pregnancy, they could have triggered off fetal cell lesions by initiating autoimmune antibody-dependent cell-mediated cytotoxicity in her three children, resulting in the unusually early onset of IDDM.
In family 2, the presence of an incomplete form of the Wolfram syndrome in the three sibs, of whom one is a different HLA type from the other two, supports the view that this syndrome is not HLA linked and that it could be a disorder distinct from classical type I diabetes. This has already been suggested in one family.8 However, as these patients were only typed for HLA-A and -B, a recombination at the DR locus of the sib with a different HLA type could not be excluded.
In both families presented, the HLA-DR2 allele did not contribute to a more favourable course of the disease, since similar clinical patterns were observed whether or not patients carried DR2.
Our observation correlates with that of Weitkamp9 who found less haplotype sharing in families with three or four affected sibs than in those with two affected sibs. This raises the question of more than one susceptibility locus,10 11 which could be more apparent in families with several affected subjects, and provides evidence suggesting genetic heterogeneity of juvenile onset IDDM.
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